Do you want to read an article? Please log in or register.
Investigation of left ventricular ejection fraction in a Swiss heart failure population: Insights into mortality and sex differences
Heart Failure
Related content
Heart Failure
The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) study
Eur J Heart Fail
Leong DP, Joseph PG, Dokainish H, Störk S, McMurray JVV, Mielniczuk LM, Sharma SK, Orlandini A, Karaye KM, Bayes-Genis A, McCready T, Grinvalds A, Balasubramanian K, Branch KR, Kragholm K, Yusuf S, on behalf of the G‐CHF Investigators
doi: 10.1002/ejhf.3550
Heart Failure
Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF
Eur J Heart Fail
Malgie J, Wilde MI, Koudstaal S, Denham R, da Fonseca CA, Swart HP, van Ofwegen CEE, Yilmaz A, Pisters R, Linssen GCM, Faber N, van Heerebeek L, van de Swaluw JEC, de Boer RA, Brunner-La Rocca HP, Brugts JJ
doi: 10.1002/ejhf.70006
Heart Failure
Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK Biobank
Cardiovasc Diabetol
Bertrand A, Zhou X, Lewis A, Monfeuga T, Gupta R, Grau V, Rodriguez B
doi: 10.1186/s12933-025-02788-4
Heart Failure
Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction
J Am Heart Assoc
Okada M, Tanaka N, Iwakura K, Onishi T, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Tamaki S, Yasumura Y, Yamada T, Sakamoto D, Hikoso S, Okada K, Nakatani D, Sotomi Y, Sakata Y, OCVC‐Heart Failure Investigators
doi: 10.1161/JAHA.124.040646
Heart Failure
Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection Fraction
JACC Heart Fail
Siqueira SRO, Pabon MA, Vaduganathan M, Claggett BL, Lam CSP, Kosiborod MN, de Boer RA, Shah SJ, Fang JC, Desai AS, Jhund PS, Inzucchi SE, Martinez F, Hernandez AF, Petersson M, McMurray JJV, Solomon SD, Vardeny O
doi: 10.1016/j.jchf.2025.102585
Heart Failure
Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry
Eur J Heart Fail
Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C
doi: 10.1002/ejhf.3565
Heart Failure
Inpatient versus outpatient diagnosis of heart failure across the spectrum of ejection fraction: a population cohort study
Heart
Wang H, Gao C, Guignard-Duff M, Cole C, Hall C, Baruah R, Das S, Gao H, Mamza JB, Lang CC, Mordi IR
doi: 10.1136/heartjnl-2024-324160
Heart, Artery and Coronary DiseasesHeart Failure
Coronary Artery Disease Doubles Excess Mortality in Patients With Heart Failure With Reduced Ejection Fraction
J Am Heart Assoc
Anker N, Olesen KKW, Thrane PG, Gyldenkerne C, Mortensen MB, Nielsen RR, Løgstrup BB, Würtz M, Nielsen JC, Maeng M
doi: 10.1161/JAHA.124.037915
COMMENTED
Heart Failure
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA(1c) levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Lancet Diabetes Endocrinol
Davies MJ, van der Meer P, Verma S, Patel S, Chinnakondepalli KM, Borlaug BA, Butler J, Kitzman DW, Shah SJ, Harring S, Salsali A, Rasmussen S, von Lewinski D, Abhayaratna W, Petrie MC, Kosiborod MN, STEP-HFpEF Trials Committees and Investigators
doi: 10.1016/S2213-8587(24)00304-8